IP Library › Granted Patent US 12,225,900
Granted Patent B2
US 12,225,900 · App. 16/962,531 · Granted Feb 18, 2025

Perfusion loop assembly for an ex-vivo liver perfusion and a method for ex-vivo liver perfusion

Inventors: Dustin Becker (Zurich, CH); Dilmurodjon Eshmuminov (Rudolfstetten, CH); Max Leo Hefti (Zurich, CH); Martin Jörg Schuler (Zurich, CH); Philipp Rudolf von Rohr (Basel, CH); Pierre-Alain Clavien (Kilchberg, CH); Rolf Graf (Zurich, CH); Lucia Bautista Borrego (Zurich, CH); Xavier Muller (Zurich, CH); Philipp Dutkowski (Zurich Zurich, CH)
Assignees: ETH Zurich; Universität Zurich
A01N1/0247A01N1/0215A01N1/0226
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,225,900
App. No.
16/962,531
Granted
Feb 18, 2025
Kind
B2
Abstract

A perfusion loop assembly for ex vivo liver perfusion includes a pump providing perfusion fluid through a line branching at a branching point into a first branch line and a second branch line. The first branch line provides a first portion of the perfusion fluid to the hepatic artery of the liver, the first branch line coupled with a gas exchanger, where the first branch line includes a flow rate sensor and/or a pressure sensor. The second branch line provides a second portion of the perfusion fluid to the portal vein of the liver; the second branch line includes a valve for controlling flow of perfusion fluid into the portal vein. The second branch line includes a flow rate sensor and/or a pressure sensor. A liver chamber assembly holds the liver ex vivo, and an outlet line for the perfusion fluid connects the liver chamber assembly and the pump.

Claims (28)

1. A perfusion loop assembly for perfusion of an ex vivo liver, comprising:

a pump and a line, wherein the pump is configured to provide a fluid flow of a perfusion fluid through the line and wherein the line branches at a branching point into a first branch line and a second branch line downstream of the pump;

the first branch line being configured to provide a first portion of the perfusion fluid to the hepatic artery (arteria hepatica propria or arteria hepatica communis) of the ex vivo liver;

the first branch line being coupled with a first gas exchanger,

wherein the first branch line comprises a port for administering additives to the perfusion fluid in the first branch line;

wherein the first branch line comprises a flow rate sensor and a pressure sensor,

the second branch line being configured to provide a second portion of the perfusion fluid to the portal vein (vena portae hepatis) of the ex vivo liver;

the second branch line further comprising a first valve for controlling the flow of the perfusion fluid into the portal vein of the ex vivo liver,

wherein the second branch line comprises a port for administering additives to the perfusion fluid in the second branch line;

wherein the second branch line comprises a flow rate sensor and a pressure sensor;

a liver chamber assembly configured to hold the ex vivo liver,

a liver outlet line configured to be attached to the vena cava (vena cava inferior) of the ex vivo liver,

the outlet line further comprising a second valve for adjusting the pressure in the outlet line at the vena cava of the ex vivo liver,

wherein the outlet line comprises a pressure sensor,

a reservoir connected to the outlet line and upstream from the pump,

a bypass between the first branch line and the second branch line, wherein the bypass connects the first branch line downstream of the gas exchanger with the second branch line downstream of the first valve, or a bypass between the first branch line and the reservoir, and

a dialysis machine for adjusting the composition of the perfusion fluid, wherein the dialysis machine is implemented between the outlet line upstream of the reservoir and the second branch line.

2. The perfusion loop assembly according claim 1 , wherein at least one of:

the first branch line, the second branch line and/or the outlet line comprise an interface with the hepatic artery of the ex vivo liver, the portal vein and/or the vena cava, respectively, and

the first branch line and the second branch line are connected to a sensor for monitoring blood gases.

3. The perfusion loop assembly according to claim 1 , wherein the outlet line comprises a sensor for monitoring the oxygen saturation SO 2 , hemoglobin and hematocrit value in the perfusion fluid.

4. The perfusion loop assembly according to claim 1 , wherein the first valve in the second branch line is a proportional pinch valve.

5. The perfusion loop assembly according to claim 1 , wherein at least one of:

the port for administering additives in the first branch line is implemented in the first branch line downstream of the gas exchanger and downstream of the bypass, and

the port for administering additives to the perfusion fluid in the second branch line is implemented in a parallel line to second branch line.

6. The perfusion loop assembly according to claim 1 , wherein a sensor for monitoring the glucose level and/or a sensor for monitoring the lactate level and/or a sensor for monitoring the ammonium level in the perfusion fluid is implemented in the loop assembly.

7. The perfusion loop assembly according to claim 1 , wherein a spectroscopic flow cell for recording fluorescence and/or absorbance spectra of at least one compound or molecule present in the perfusate is implemented in the loop assembly.

8. The perfusion loop assembly according to claim 1 , wherein a valve and a flow rate sensor are implemented in the bypass between the first branch line and the second branch line.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2021
From: BECKER, DUSTIN; ESHMUMINOV, DILMURODJON; HEFTI, MAX LEO; SCHULER, MARTIN JÖRG; RUDOLF VON ROHR, PHILIPP; CLAVIEN, PIERRE-ALAIN; GRAF, ROLF; BAUTISTA BORREGO, LUCIA; MULLER, XAVIER; DUTKOWSKI, PHILIPP
To: ETH ZURICH; UNIVERSITÄT ZURICH
Reel/Frame 057338/0565 →
Priority Claims (3)
EP 18152562 · Jan 19, 2018 · regional
EP 18169518 · Apr 26, 2018 · regional
EP 18204583 · Nov 6, 2018 · regional
Continuity (1)
Related Publication 20200375178A1 · Dec 3, 2020
References Cited (99)
US 3515370A · Jester et al. · 1970 [cited by applicant]
US 4192308A · Michaels · 1980 [cited by applicant]
US 5141847A · Sugimachi et al. · 1992 [cited by applicant]
US 5786136A · Mayer · 1998 [cited by applicant]
US 5856081A · Fahy · 1999 [cited by applicant]
US 5890518A · Fischerkeller · 1999 [cited by applicant]
US 7410474B1 · Friend et al. · 2008 [cited by applicant]
US 7572622B2 · Hassanein et al. · 2009 [cited by applicant]
US 7811808B2 · van der Plaats et al. · 2010 [cited by applicant]
US 7977042B2 · Lee et al. · 2011 [cited by applicant]
US 8287580B2 · Rakhorst et al. · 2012 [cited by applicant]
US 8927257B2 · Hutzenlaub et al. · 2015 [cited by applicant]
US 8986978B2 · Brassil · 2015 [cited by applicant]
US 9457179B2 · Hassanein et al. · 2016 [cited by applicant]
US 9756848B2 · van der Plaats et al. · 2017 [cited by applicant]
US 10076112B2 · Hassanein et al. · 2018 [cited by applicant]
US 10362780B2 · Kay et al. · 2019 [cited by applicant]
US 10433538B2 · Fontes et al. · 2019 [cited by applicant]
US 10634686B2 · Chaves Fontes et al. · 2020 [cited by applicant]
US 20040058432A1 · Owen · 2004 [cited by examiner]
US 20050147958A1 · Hassanein et al. · 2005 [cited by applicant]
US 20060148062A1 · Hassanein et al. · 2006 [cited by applicant]
US 20070009881A1 · Artz et al. · 2007 [cited by applicant]
US 20070048725A1 · Arrington · 2007 [cited by applicant]
US 20080017194A1 · Hassanein et al. · 2008 [cited by applicant]
US 20090197240A1 · Fishman et al. · 2009 [cited by applicant]
US 20100117011A1 · Kitano et al. · 2010 [cited by applicant]
US 20110065170A1 · Fondevila Campo et al. · 2011 [cited by applicant]
US 20120213798A1 · Levy et al. · 2012 [cited by applicant]
US 20130011823A1 · Hassanein et al. · 2013 [cited by applicant]
US 20130177972A1 · Green et al. · 2013 [cited by applicant]
US 20140011182A1 · Van Sickle et al. · 2014 [cited by applicant]
US 20140017658A1 · Steinman et al. · 2014 [cited by applicant]
US 20140017662A1 · Kravitz et al. · 2014 [cited by applicant]
US 20140308654A1 · Kay et al. · 2014 [cited by applicant]
US 20140377849A1 · Kay et al. · 2014 [cited by applicant]
US 20150004677A1 · Kay et al. · 2015 [cited by applicant]
US 20150173348A1 · Brasile · 2015 [cited by applicant]
US 20150342177A1 · Hassanein et al. · 2015 [cited by applicant]
US 20160262634A1 · Steen et al. · 2016 [cited by applicant]
US 20170339945A1 · Freed · 2017 [cited by applicant]
US 20190141988A1 · Kobayashi et al. · 2019 [cited by applicant]
US 20200253194A1 · Clavien · 2020 [cited by examiner]
US 20200375178A1 · Becker et al. · 2020 [cited by applicant]
CN 1543785A · 2004 [cited by applicant]
CN 103719075A · 2014 [cited by applicant]
CN 105379707A · 2016 [cited by applicant]
CN 205124849U · 2016 [cited by applicant]
CN 105660604A · 2016 [cited by applicant]
CN 206403020U · 2017 [cited by applicant]
CN 214339668U · 2021 [cited by examiner]
DE 2603139A1 · 1976 [cited by applicant]
EP 0702515B1 · 1996 [cited by applicant]
EP 2133610A1 · 2009 [cited by applicant]
EP 2633755A1 · 2013 [cited by applicant]
EP 2009986B1 · 2015 [cited by applicant]
EP 2203046B1 · 2015 [cited by applicant]
EP 3459351A1 · 2019 [cited by applicant]
WO WO0200293A1 · 2002 [cited by examiner]
WO WO2005022995A1 · 2005 [cited by examiner]
WO 2007014380A2 · 2007 [cited by applicant]
WO 2008108996A1 · 2008 [cited by applicant]
WO 2009138446A2 · 2009 [cited by applicant]
WO 2011050459A1 · 2011 [cited by applicant]
WO 2011062621A2 · 2011 [cited by applicant]
WO 2013029044A1 · 2013 [cited by applicant]
WO 2013032319A1 · 2013 [cited by applicant]
WO WO2013068753A1 · 2013 [cited by examiner]
WO 2014001592A1 · 2014 [cited by applicant]
WO 2014059316A1 · 2014 [cited by applicant]
WO 2015042602A1 · 2015 [cited by applicant]
WO 2015187737A1 · 2015 [cited by applicant]
WO 2016090498A1 · 2016 [cited by applicant]
WO 2017200089A1 · 2017 [cited by applicant]
WO 2018015548A2 · 2018 [cited by applicant]
WO 2019141809A1 · 2019 [cited by applicant]
Ravikumar et al. “Normothermic liver preservation: a new paradigm?,” Transplant International, 28 (2015) 690-699. (Year: 2015). [cited by examiner]
Schön et al., Liver Transplantation After Organ Preservation with Normothermic Extracorporeal Perfusion, Ann. Surg., Jan. 2001, pp. 114-123, vol. 233, No. 1. [cited by applicant]
Barbas et al., “Ex-vivo liver perfusion for organ preservation: Recent advances in the field”, Transplantation Reviews, 2016, pp. 154-160, vol. 30. [cited by applicant]
Boyer, “Bile Formation and Secretion”, Compr Physiol, 2013, pp. 1035-1078, vol. 3. [cited by applicant]
Chapman et al., “Flavoprotein Protocols”, Methods in Molecular Biology, 1999, vol. 131, Humana Press Inc., Totowa, NJ. [cited by applicant]
Chen et al., “Coalescence-Induced Jumping of Multiple Condensate Droplets on Hierarchical Superhydrophobic Surfaces”, Sci. Rep, 2016, pp. 1-11, vol. 6:18649. [cited by applicant]
Chouchani et al., “Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS”, Nature, 2014, pp. 431-435, vol. 515. [cited by applicant]
Dash et al., “Erratum to: Blood HbO2 and HbCO2 Dissociation Curves at Varied O2, CO2, pH, 2,3-DPG and Temperature Levels”, Annals of Biomedical Engineering, 2010, pp. 1683-1701, vol. 38:4. [cited by applicant]
Fitzgerald et al., “Assessment of Renal Ischemia by Optical Spectroscopy”, Journal of Surgical Research, 2004, pp. 21-28, vol. 122. [cited by applicant]
Golse et al., “Arterial Lactate Concentration at the End of Liver Transplantation is an Early Predictor of Primary Graft Dysfunction”, Ann Surg, 2018, pp. 1-8. [cited by applicant]
Hoefeijzers et al., “The Pulsatile Perfusion Debate in Cardiac Surgery: Answers From the Microcirculation?”, J. Cardiothorac. Vasc. Anesth., 2015, pp. 761-767, vol. 29:3. [cited by applicant]
Hohenester et al., “A Biliary HCO3-Umbrella Constitutes a Protective Mechanism Against Bile Acid-Induced Injury in Human Cholangiocytes,” Hepatology, 2012, pp. 173-183, vol. 55:1. [cited by applicant]
Imber et al., “Optimisation of Bile Production during Normothermic Preservation of Porcine Livers”, American Journal of Transplantation, 2002, pp. 593-599, vol. 2. [cited by applicant]
Imber et al., “Advantages of Normothermic Perfusion Over Cold Storage in Liver Preservation”, Transplantation, 2002, pp. 701-709, vol. 73:5. [cited by applicant]
Jablonski et al., “Studies on the Isolated Perfused Pig Liver”, Brit. J. Surg., 1971, pp. 129-137, vol. 58:2. [cited by applicant]
Kahl et al., “Critical Role of Flavin and Glutathione in Complex I-Mediated Bioenergetic Failure in Brain Ischemia/Reperfusion Injury”, Stroke, 2018, pp. 1223-1231, vol. 49. [cited by applicant]
Kaiser et al., “Die Entwicklung eines leichten, automatisch gesteuerten Lappen-Containers zum Direkttransfer und zur warmen Langzeitkonservierung freier, mikrochirurgischer Lappen”, European Archives of Oto-Rhino-Laryng… [cited by applicant]
Kanno et al., “Regulation of cholangiocyte bicarbonate secretion”, Am J Physiol Gastrointest Liver Physiol, 2001, vol. 281, pp. G612-G625. [cited by applicant]
Op Den Dries et al., “Ex vivo Normothermic Machine Perfusion and Viability Testing of Discarded Human Donor Livers”, American Journal of Transplantation, 2013, pp. 1327-1335, vol. 13. [cited by applicant]
Ravikumar et al., “Normothermic liver preservation: a new paradigm?”, Steunstichting ESOT, 2015, pp. 690-699, vol. 28. [cited by applicant]
Steinacher et al., “Therapeutic Mechanisms of Bile Acids and Nor-Ursodeoxycholic Acid in Non-Alcoholic Fatty Liver Disease”, Dig Dis, 2017, pp. 282-287, vol. 35. [cited by applicant]
Trauner et al., “Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic Disorders”, Dig Dis, 2015, pp. 433-439, vol. 33. [cited by applicant]
Vekemans et al., “Artificial Circulation of the Liver: Machine Perfusion as a Preservation Method in Liver Transplantation”, The Anatomical Record, 2008, pp. 735-740, vol. 291. [cited by applicant]